Resonance Health Limited (ASX:RHT) insider Simon Panton purchased 1,000,000 shares of the firm’s stock in a transaction on Tuesday, February 5th. The stock was acquired at an average price of A$0.07 ($0.05) per share, for a total transaction of A$71,000.00 ($50,354.61).
RHT traded down A$0.01 ($0.01) during trading on Wednesday, hitting A$0.08 ($0.05). The company’s stock had a trading volume of 12,856,370 shares. The company has a market capitalization of $30.99 million and a P/E ratio of 77.00.
ILLEGAL ACTIVITY NOTICE: “Resonance Health Limited (RHT) Insider Simon Panton Purchases 1,000,000 Shares” was reported by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://www.com-unik.info/2019/02/13/resonance-health-limited-rht-insider-simon-panton-purchases-1000000-shares.html.
Resonance Health Company Profile
Resonance Health Limited, a healthcare company, develops and delivers non-invasive medical imaging software and services worldwide. Its flagship product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of liver iron concentration. The company also offers Cardiac T2, a dual analysis service with FerriScan to provide information regarding body iron stores; HepaFat-Scan, a magnetic resonance imaging (MRI) based tool for the measurement of volumetric liver fat fraction; and Bone Marrow R2-MRI for the assessment of iron levels in the bone marrow.
Recommended Story: What is a put option?
Receive News & Ratings for Resonance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resonance Health and related companies with MarketBeat.com's FREE daily email newsletter.